All
Anticonvulsant additive reduces herpetic pain
March 1st 2002New Orleans - Data from an open-label study suggest that the anticonvulsant drug gabapentin (Neurontin) added to antiviral treatment during acute herpes zoster infection may further reduce the duration and severity of postherpetic neuralgia, Mathijs H. Brentjens, M.S., M.D., reported at the annual meeting of the American Academy of Dermatology.
Hemangiomas, malformations continue to evolve in definition
March 1st 2002New Orleans - Just like the endothelial cells that proliferateand produce hemangiomas, the field of study that surrounds these benigntumors of infancy and childhood continues to be a work in progress, MoiseL. Levy, M.D., said at the 60th annual meeting of the American Academy ofDermatology.
The human genome: Applying it to practice
March 1st 2002Miami Beach, Fla. - Dermatologists and pediatricians often areafraid of learning the technicalities of the human genome. However, onlya basic knowledge, an understanding of how genetics might apply to practice,and a relationship with a geneticist who can answer your questions are necessaryto use the tools available today, Judith G. Hall, O.C., M.D., said.
Derms divulge how they have such flawless skin
March 1st 2002* Never use the same product year-round. "Because skin isa living organ that's constantly affected by everything from hormones tohumidity, I use a variety of products - some only in certain seasons andothers just on certain days," says Susan Taylor, M.D., director, Skinof Color Center at St. Luke's Roosevelt Hospital, New York.
Oritavancin shortens treatment time for complicated skin-structure infections
March 1st 2002Chicago - Oritavancin (InterMune), an investigational glycopeptidewith activity against a wide range of Gram-positive pathogens, has beenshown to cut the treatment time in half for complicated skin and skin structureinfections (CSSIs) compared to current standard therapy with vancomycinplus cephalexin, Margaret Wasilewski, M.D., said at the 41st InterscienceConference on Antimicrobial Agents & Chemotherapy.
Patients rights bill: A new political football?
March 1st 2002Lobbyists for insurance companies, the managed care industry, and dozensof large trade associations are worried. Their old buddy, PresidentBush, has been talking to one of their biggest enemies, Sen. Ted Kennedy(D-MA), about, heaven forbid, managed care reform.
New acne drug battles bacterial resistance
February 2nd 2002Chicago - A new acne drug under development shows promise of efficacyand does not produce resistance in bacteria that causes the condition. Thenews comes at a time when the bacterium P. acnes demonstrated resistanceto traditional treatment antibiotics tetracycline and erythromycin.
Novel vaccine promising in treatment of genital warts
February 1st 2002Baltimore - Phase II study results point to the potential roleof HspE7 as a safe and effective immunotherapeutic agent for the treatmentof genital warts and other HPV-related sexually transmitted diseases, KeertiV. Shah, M.D., said.
Maligned flutamide exhibits acne, AGA benefits
February 1st 2002São Paulo, Brazil - Contrary to foregoing reports of significantside effects and high cost, Denise Steiner, M.D., Ph.D., contends that theanti-androgen drug flutamide 250 mg (Euflex, Euflexin) is a safe and effectivetherapy for treating female acne and androgenetic alopecia with an overallpositive relation of cost to benefit.
Treating warts necessitates communication
February 1st 2002The treatment of warts can be a frustrating experience for both the dermatologistas well as the patient and/or patient's family. The provider needs to bewell versed in the many rules and regulations that govern the billing ofwarts (e.g., medical necessity issues, CPT and ICD-9 coding) while the patientneeds to be educated on the nature of the condition and the complexitiesassociated with the treatment arsenal.
Cosmetic Conundrums with Zoe Diana Draelos, M.D.
February 1st 2002Q. What is a 2-in-1 shampoo?A. Two-in-1 shampoo is a shampoo designed to cleanse and condition in one step. The original 2-in-1 shampoos neither conditioned well nor cleansed well, but the new varieties have taken advantage of modern silicone technology.